C12N 15/8673
Special methods for packaging systems
Official title: {Special methods for packaging systems}
C12N15/8673 (Special methods for packaging systems) appears on 9 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 13
- Assignees
- 8
- Inventors
- 15
- Latest grant
- 19 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 3 |
| 2019 | 1 | 2 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and constructs for production of lentiviral vector19 Aug 2025US 12,391,960 B2Lonza Walkersville, Inc.
- Methods and compositions for modified factor IX fusion proteins20 May 2025US 12,304,944 B2The University of North Carolina at Chapel Hill
- Methods and constructs for production of lentiviral vector16 Jul 2024US 12,037,599 B2Lonza Walkersville, Inc.
- Methods and compositions for modified factor IX fusion proteins24 Jan 2023US 11,560,418 B2The University of North Carolina at Chapel Hill
- Point-of-care and/or portable platform for gene therapy10 Nov 2020US 10,828,333 B2Fred Hutchinson Cancer Research Center
- Stem cell based delivery of tumor-specific retroviral vectors21 May 2026US 2026/0139275 A1Abintus Bio, Inc.
- Methods and constructs for production of lentiviral vector21 Aug 2025US 2025/0263749 A1Lonza Walkersville, Inc.
- Methods and constructs for production of lentiviral vector10 Oct 2024US 2024/0336936 A1Lonza Walkersville, Inc.
- Methods and compositions for modified factor ix fusion proteins6 Jul 2023US 2023/0212263 A1The University of North Carolina at Chapel Hill
- Methods and constructs for production of lentiviral vector4 Mar 2021US 2021/0062220 A1Lonza Walkersville, Inc.
Most cited
By later US patents